A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup.

Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations.

LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β(1-42) Fibrils.

Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorder.

COMT but Not 5HTTLPR Gene Is Associated with Depression in First-Episode Psychosis: The Role of Stressful Life Events.

Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies.

Mapping genomic loci implicates genes and synaptic biology in schizophrenia.

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.

Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review.

Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia.

Genetic Dissection of Temperament Personality Traits in Italian Isolates.

Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients.

Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial).

Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy.

The potential impact of mammographic breast arterial calcification on physician practices in a primary care setting.